Total Payments
$12,603
2022 Payments
$199.17
Companies
51
Transactions
990
Medicare Patients
1,126
Medicare Billing
$117,554
Payment Breakdown by Category
Food & Beverage$12,552 (99.6%)
Education$51.21 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,552 | 983 | 99.6% |
| Education | $51.21 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,606 | 84 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,134 | 84 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,068 | 112 | $0 (2022) |
| GlaxoSmithKline, LLC. | $901.13 | 61 | $0 (2021) |
| PFIZER INC. | $741.05 | 111 | $0 (2020) |
| Allergan, Inc. | $647.33 | 34 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $606.71 | 69 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $596.74 | 63 | $0 (2020) |
| Amgen Inc. | $562.78 | 46 | $0 (2020) |
| ABBVIE INC. | $503.39 | 28 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $199.17 | 4 | Janssen Pharmaceuticals, Inc ($150.42) |
| 2021 | $450.05 | 20 | Novo Nordisk Inc ($235.62) |
| 2020 | $1,252 | 77 | Novo Nordisk Inc ($292.45) |
| 2019 | $3,780 | 293 | Novo Nordisk Inc ($483.02) |
| 2018 | $3,757 | 312 | GlaxoSmithKline, LLC. ($501.59) |
| 2017 | $3,164 | 284 | Janssen Pharmaceuticals, Inc ($384.68) |
All Payment Transactions
990 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $134.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/21/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/21/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: Diabetes | ||||||
| 10/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: Diabetes | ||||||
| 08/19/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/16/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes | ||||||
| 08/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Diabetes | ||||||
| 08/05/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $25.95 | General |
| Category: Cardiovascular | ||||||
| 07/22/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Diabetes | ||||||
| 06/16/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 05/19/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Diabetes | ||||||
| 05/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes | ||||||
| 03/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Diabetes | ||||||
| 01/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 01/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Diabetes | ||||||
| 12/10/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 7 | 451 | 760 | $162,322 | $58,575 |
| 2020 | 12 | 675 | 1,075 | $193,603 | $58,979 |
Total Patients
1,126
Total Services
1,835
Medicare Billing
$117,554
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 228 | 500 | $124,000 | $41,713 | 33.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 60 | 60 | $15,960 | $8,001 | 50.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 92 | $15,640 | $5,254 | 33.6% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 31 | 31 | $2,232 | $2,059 | 92.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 14 | 19 | $3,249 | $856.85 | 26.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 35 | 35 | $942.00 | $600.46 | 63.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 13 | 23 | $299.00 | $90.82 | 30.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 266 | 603 | $146,529 | $42,497 | 29.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 91 | $15,015 | $3,666 | 24.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 49 | 50 | $5,206 | $3,452 | 66.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 47 | 47 | $4,277 | $2,854 | 66.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 13 | 13 | $3,302 | $1,515 | 45.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 23 | 26 | $4,788 | $1,186 | 24.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 24 | $1,568 | $993.45 | 63.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 53 | 53 | $1,272 | $902.96 | 71.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 70 | 85 | $8,415 | $836.00 | 9.9% |
| 99423 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | Office | 2020 | 17 | 19 | $2,109 | $646.44 | 30.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 14 | 14 | $472.00 | $236.58 | 50.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 28 | 50 | $650.00 | $193.12 | 29.7% |
About Dr. William Lee, MD
Dr. William Lee, MD is a Internal Medicine healthcare provider based in Tacoma, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285626325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Lee, MD has received a total of $12,603 in payments from pharmaceutical and medical device companies, with $199.17 received in 2022. These payments were reported across 990 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($12,552).
As a Medicare-enrolled provider, Lee has provided services to 1,126 Medicare beneficiaries, totaling 1,835 services with total Medicare billing of $117,554. Data is available for 2 years (2020–2021), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Tacoma, WA
- Active Since 08/16/2005
- Last Updated 06/04/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285626325
Products in Payments
- XARELTO (Drug) $864.61
- Ozempic (Drug) $784.56
- INJECTAFER (Drug) $402.24
- JARDIANCE (Drug) $389.97
- JANUVIA (Drug) $368.67
- TOUJEO (Drug) $355.67
- TRULICITY (Drug) $283.52
- ENTRESTO (Drug) $282.50
- ANORO (Drug) $281.72
- Saxenda (Drug) $279.14
- TRELEGY ELLIPTA (Drug) $269.57
- FARXIGA (Drug) $268.58
- Trintellix (Drug) $265.54
- TRADJENTA (Drug) $263.22
- Creon (Drug) $256.93
- VRAYLAR (Drug) $246.07
- CHANTIX (Drug) $236.36
- Victoza (Drug) $223.26
- Amitiza (Drug) $206.70
- INVOKANA (Drug) $203.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tacoma
John Sun, Md, MD
Internal Medicine — Payments: $305,883
Internal Medicine $305,883
Dr. Charles Minn, M.d, M.D
Internal Medicine — Payments: $66,588
Internal Medicine $66,588
Dr. Royce Morrison, M.d, M.D
Internal Medicine — Payments: $55,477
Internal Medicine $55,477
Lillian Wang, Md, MD
Internal Medicine — Payments: $25,238
Internal Medicine $25,238
Daniel Ginsberg, Md, MD
Internal Medicine — Payments: $13,981
Internal Medicine $13,981
Weiqiang Gao, M.d, M.D
Internal Medicine — Payments: $13,645
Internal Medicine $13,645